Meidong Zhu

Author PubWeight™ 23.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006 2.72
2 Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 2004 1.86
3 Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 2005 1.30
4 Familial asymptomatic macular telangiectasia type 2. Ophthalmology 2009 1.12
5 Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology 2009 1.11
6 Metamorphopsia after successful retinal detachment surgery: an optical coherence tomography study. Acta Ophthalmol Scand 2005 1.03
7 Loss of Müller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology 2013 1.01
8 Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial. Ophthalmology 2011 0.97
9 Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration. Retina 2015 0.87
10 Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial. Clin Experiment Ophthalmol 2010 0.86
11 The interaction of indocyanine green with human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2005 0.86
12 Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. Acta Ophthalmol 2008 0.86
13 Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. Br J Ophthalmol 2012 0.85
14 Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. Invest Ophthalmol Vis Sci 2008 0.85
15 Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. Br J Ophthalmol 2007 0.83
16 In vitro study of the effects of lens extract on rat retinal neuron survival and neurite outgrowth. Ophthalmic Res 2009 0.81
17 Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. Invest Ophthalmol Vis Sci 2009 0.81
18 Anti-retinal antibodies in patients with macular telangiectasia type 2. Invest Ophthalmol Vis Sci 2013 0.81
19 Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes. Ophthalmic Res 2015 0.80
20 Basement membrane changes in capillaries of the ageing human retina. Br J Ophthalmol 2011 0.79
21 Intravitreal injection of triamcinolone acetonide for immune recovery uveitis. Retina 2006 0.76
22 Triamcinolone for occult exudative age-related macular degeneration. Am J Ophthalmol 2006 0.75
23 Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial. BMC Ophthalmol 2014 0.75
24 Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema. Clin Ophthalmol 2013 0.75
25 Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes. Ophthalmologica 2017 0.75
26 Reply. Cornea 2017 0.75
27 Influence of Retinal Pathology on the Reliability of Macular Thickness Measurement: A Comparison Between Optical Coherence Tomography Devices. Ophthalmic Surg Lasers Imaging Retina 2017 0.75
28 Measurement of retinal arteriolar diameters from auto scale phase congruency with fuzzy weighting and L1 regularization. Conf Proc IEEE Eng Med Biol Soc 2012 0.75
29 Intravitreal triamcinolone. Ophthalmology 2009 0.75